MedPath

Drug therapy of Helicobacter pylori infectio

Not Applicable
Recruiting
Conditions
Helicobacter pylori infection.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT2017062234698N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

patients with digestive disorders such as recurrent abdominal pain; gastrointestinal bleeding and dyspepsia.
Exclusion criteria: having a history of taking medications such as antibiotics; bismuth; proton pump inhibitors; Histamine receptor antagonists and non steroid anti inflammatory drugs in the last 4 weeks.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori in the corpus specimen. Timepoint: Four weeks after the last day of treatment. Method of measurement: Standard protocol.;Histopathology of stomach biopsy. Timepoint: Four weeks after the last day of treatment. Method of measurement: Standard protocol.;Helicobacter pylori in anther sample. Timepoint: Four weeks after the last day of treatment. Method of measurement: Standard protocol.;Rapid urease test. Timepoint: Four weeks after the last day of treatment. Method of measurement: Standard protocol.;Helicobacter pylori stool antigen. Timepoint: Four weeks after the last day of treatment. Method of measurement: Standard protocol.
Secondary Outcome Measures
NameTimeMethod
Body mass index. Timepoint: Four weeks after the last day of treatment. Method of measurement: Body mass index formula.
© Copyright 2025. All Rights Reserved by MedPath